Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Timus Networks Provides Oracle Cloud Customers with Enhanced Network Protection and Secure Remote Access
-
OKX Wallet Now Integrated with Kryptomon
-
Adaptive Announces IVDR Certification for clonoSEQ® in European Union
-
KANZHUN LIMITED Announces Adoption of New Share Repurchase Program
-
Onex Partners to Acquire Farsound
-
GURU Organic Energy to Report Third Quarter 2024 Results
-
BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer
-
Notable Labs to Present Data on September 4th at SOHO 2024
-
Electra Engages Altitude Capital Consultants
-
Ollie’s Bargain Outlet Holdings, Inc. Reports Second Quarter Fiscal 2024 Financial Results
-
BridgeBio to Present Additional Analyses from the Phase 3 ATTRibute-CM Trial of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the ESC Congress 2024 and the HFSA Annual
-
MasterCraft Boat Holdings, Inc. Reports Fiscal 2024 Results
-
Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease
-
Zevra Therapeutics to Participate at Upcoming Investor Conferences
-
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
-
Chart Industries and Element Resources Partner on Hydrogen Eco-System Deployment
-
Pyxis Oncology to Participate in Two Upcoming Investor Conferences
-
Inaugural Pre-JPM Partnering Week to Wrap Up 2024, Prepare for 2025
-
Nu:ionic Technologies and RW Energy Announce Strategic Alliance for Distributed Scale Hydrogen Production and CO2 Capture Projects
-
Researchers call for individualized gene therapies to be more widely accessible
-
Tims China Announces Second Quarter 2024 Financial Results
-
Innofactor Plc: Managers’ Transactions – Jørn Ellefsen
-
OKX Announces Support for MATIC Token Migration to POL
-
Nikkiso Clean Energy & Industrial Gases Group Announces It Will Double Manufacturing Capacity in Europe
-
Nikkiso Clean Energy & Industrial Gases Group Announces It Will Double Manufacturing Capacity in Europe
-
Lifecore Biomedical Announces Chief Financial Officer Transition
-
Arvinas to Participate in Upcoming Investor Conferences
-
Mikra Ships FOCUS Ahead of Schedule and Prepares for Marketing Push
-
17 Education & Technology Group Inc. to Report Second Quarter 2024 Unaudited Financial Results on September 4, 2024
-
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
-
POET Streamlines its Global Engineering Organization in Response to AI Market Demand
-
Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Re
-
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
-
BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
-
17 Education & Technology Group Inc. to Report Second Quarter 2024 Unaudited Financial Results on September 4, 2024
-
Adagene to Participate in Investor Conferences in September
-
G-III Apparel Group Announces Date for Second Quarter 2025 Results
-
Rivalry Reports Second Quarter 2024 Results; Rivalry Token Drives $1.7 Million in Additional Revenue, Accelerating Crypto Expansion Efforts in the Third Quarter
-
Destination XL Group, Inc. Reports Second Quarter Financial Results
-
Vigil Neuroscience to Present at Upcoming September Investor Conferences
-
GCT Semiconductor Holding, Inc. to Present at the 2024 Gateway Conference on September 4th
-
Malibu Boats, Inc. Announces Fourth Quarter Fiscal 2024 Results
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Amplify ETFs Declares August Income Distributions for its ETFs
-
C4 Therapeutics to Participate in Upcoming September Investor Conferences
-
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
-
TScan Therapeutics to Participate in Upcoming Investor Conferences
-
Alector to Participate in Upcoming Healthcare Conferences
-
IDEX Biometrics – Approved prospectus 29 August 2024
